From: Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning
 | Average Dose in Gy | ||
---|---|---|---|
PTV + 10 | PTV + 20 | CortexPTV + 20 | |
IMRT | 56.1 ± 0.9 | 44.9 ± 3.5 | 41.4 ± 4.9 |
IMRT with CS | 53.5 ± 0.7 | 41.3 ± 2.8 | 33.4 ± 3.6 |
Robust | 53.9 ± 1.5 | 42.1 ± 3.9 | 37.2 ± 4.9 |
Robust with CS | 51.7 ± 0.9 | 39.4 ± 3.1 | 31.3 ± 3.6 |